New insights into the link between the appendix and Parkinson's
The media reports on a large-scale study that suggests the removal of the appendix may increase the risk of Parkinson's.
Phase II trial is underway investigating a gene therapy for Parkinson's
Axovant Gene Therapies Ltd., a company developing innovative gene therapies, has announced they are entering the next stage of a phase II gene therapy trial for Parkinson's.
Blood pressure drug fails in phase 3 Parkinson's trial
The STEADY-PD clinical trial has failed to show that isradipine is an effective treatment to slow or stop progression in early Parkinson's.
Boost to fast-track access to new medicines and technology through the NHS
The government initiative to fast-track access to new treatments and services is being expanded, potentially shaving years off the time it takes for people with Parkinson's to benefit from innovations in research.
Malaria drug shows promise in Parkinson's model in the lab
Research shows that problems with recycling in brain cells in Parkinson's are overcome by the malaria drug clioquinol.
Scottish Parliament backs specialist services for people with Parkinson's
News about a debate on Parkinson's services held in the Scottish Parliament
Unique award could revolutionise use of exercise as Parkinson's treatment
News about joint work with the Scottish Government to research exercise and impact it has on Parkinson's.
Experimental spinal stimulation shows promise for reducing freezing
Results from a trial of spinal cord stimulation carried out in Ontario, Canada highlights its potential for improving walking in Parkinson's.
World Parkinson's Day survey reveals harassment faced by people with Parkinson's
Figures released on World Parkinson's Day reveal astonishing levels of harassment and discrimination faced by people with Parkinson's.
Survey Reveals Shocking Lack of Public Awareness in Northern Ireland
Figures reveal for the first time the shocking lack of public awareness around Parkinson's and its symptoms despite it being the second most prevalent neurodegenerative condition after Alzheimer's.